Study demonstrates the effectiveness of raloxifene in treating inflammatory processes associated with COVID-19
Women have a lower range of ‘normal’ blood pressure than men
16 February 2021Delayed medical treatment of high-impact injuries: A lesson from the Syrian civil war
16 February 2021Study demonstrates the effectiveness of raloxifene in treating inflammatory processes associated with COVID-19
Researchers from the UPC’s Molecular Biotechnology Centre show that a drug for osteoporosis called raloxifene may inhibit molecules involved in the inflammatory processes associated with COVID-19.
